Covered recipient · General Payments record
MEERA SONI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$1,168.51
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $607.49 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $306.95 | 19 |
| Lundbeck LLC | $59.87 | 3 |
| Genentech USA, Inc. | $55.91 | 3 |
| UCB, Inc. | $54.33 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $23.75 | 1 |
| Aurinia Pharma U.S., Inc. | $22.49 | 1 |
| SCILEX PHARMACEUTICALS INC. | $18.69 | 1 |
| LivaNova USA, Inc. | $18.34 | 1 |
| GlaxoSmithKline, LLC. | $17.85 | 1 |
| SK Life Science, Inc. | $16.13 | 1 |
| Kyowa Kirin, Inc. | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.90 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139028 | CMS |
| ABBVIE INC. | $21.42 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139030 | CMS |
| ABBVIE INC. | $9.55 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139032 | CMS |
| ABBVIE INC. | $10.07 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139034 | CMS |
| ABBVIE INC. | $18.36 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139036 | CMS |
| ABBVIE INC. | $0.80 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139038 | CMS |
| ABBVIE INC. | $0.85 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139040 | CMS |
| ABBVIE INC. | $17.68 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139042 | CMS |
| ABBVIE INC. | $18.10 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139044 | CMS |
| ABBVIE INC. | $11.75 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139046 | CMS |
| ABBVIE INC. | $31.50 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139048 | CMS |
| ABBVIE INC. | $28.77 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139050 | CMS |
| ABBVIE INC. | $23.34 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139052 | CMS |
| ABBVIE INC. | $24.66 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139054 | CMS |
| ABBVIE INC. | $13.64 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139056 | CMS |
| ABBVIE INC. | $13.75 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139058 | CMS |
| ABBVIE INC. | $9.94 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139060 | CMS |
| ABBVIE INC. | $13.22 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139062 | CMS |
| ABBVIE INC. | $29.65 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106139064 | CMS |
| Aurinia Pharma U.S., Inc. | $22.49 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150692556 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $23.75 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144456541 | CMS |
| Genentech USA, Inc. | $16.99 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133067685 | CMS |
| Genentech USA, Inc. | $20.70 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133067681 | CMS |
| Genentech USA, Inc. | $18.22 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133067677 | CMS |
| GlaxoSmithKline, LLC. | $17.85 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116649893 | CMS |
| Kyowa Kirin, Inc. | $13.18 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127037306 | CMS |
| LivaNova USA, Inc. | $18.34 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152788131 | CMS |
| Lundbeck LLC | $24.46 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145971250 | CMS |
| Lundbeck LLC | $15.41 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145971252 | CMS |
| Lundbeck LLC | $20.00 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145971254 | CMS |
| SCILEX PHARMACEUTICALS INC. | $18.69 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136216403 | CMS |
| SK Life Science, Inc. | $16.13 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154152845 | CMS |
| UCB, Inc. | $27.49 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351820 | CMS |
| UCB, Inc. | $26.84 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351824 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.